Ullrich Wüllner

14.4k citations

202 papers · 9.6k indexed · 3 hit papers · h-index 53

Impact in

Neurology top 0.2%
- Parkinson's Disease Mechanisms and Treatments
- Neurological disorders and treatments
Cellular and Molecular Neuroscience top 0.2%
- Genetic Neurodegenerative Diseases
- Neuroscience and Neuropharmacology Research
- Nuclear Receptors and Signaling

Papers in

Neurology 103
- Parkinson's Disease Mechanisms and Treatments 75
- Neurological disorders and treatments 39
Cellular and Molecular Neuroscience 96
- Genetic Neurodegenerative Diseases 44
- Neuroscience and Neuropharmacology Research 24
- Nuclear Receptors and Signaling 19

Co-authors: Thomas Klockgether Ina Schmitt Oliver Kaut Bernd O. Evert Jörg B. Schulz Michael Weller Michael T. Heneka Martina Minnerop
Journals: Movement Disorders (15 papers)Journal of Neural Transmission (8 papers)Journal of Neurology (6 papers)Experimental Neurology (6 papers)Scientific Reports (5 papers)
Partner nations: Germany United States United Kingdom

In The Last Decade

Ullrich Wüllner

197 papers receiving 9.4k citations

Hit Papers

align trajectories log scale

Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naïve Parkinson’s disease patients 2017 · 461 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2017 Genome Medicine
2013 Scientific Reports
2005 Human Molecular Genetics

Peers

Countries citing papers authored by Ullrich Wüllner

Since Specialization

Citations

This map shows the geographic impact of Ullrich Wüllner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ullrich Wüllner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ullrich Wüllner more than expected).

Fields of papers citing papers by Ullrich Wüllner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ullrich Wüllner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ullrich Wüllner. The network helps show where Ullrich Wüllner may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ullrich Wüllner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ullrich Wüllner Line = papers co-authored together Ullrich Wüllner links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The Alpha-Synuclein Gene (SNCA) is a Genomic Target of Methyl-CpG Binding Protein 2 (MeCP2)—Implications for Parkinson’s Disease and Rett Syndrome Molecular Neurobiology ·Louis C. Rus, Bernd O. Evert, Amit Sharma, Ramin Berenji, Chris Murgatroyd, Ullrich Wüllner	2024	7
2	Automatic planning of MR-guided transcranial focused ultrasound treatment for essential tremor SHILAP Revista de lepidopterología ·Jan Klein, A. Roundtree-Schmotzer, Sean Mulligan, W.V. Dmitriev, Neeraj Upadhyay, Н. В. Пашкевич, Frederic Carsten Schmeel, Valeri Borger, G. A. Karlova, Itay Rachmilevitch, А. П. Коротков, Ullrich Wüllner, Jürgen Jenne	2023	0
3	The heterogeneity of Parkinson’s disease Journal of Neural Transmission ·Ullrich Wüllner, Per Borghammer, Chi‐un Choe, Ilona Csóti, Björn Falkenburger, Thomas Gasser, Paul Lingor, Peter Riederer	2023	41
4	Aneurysm size and blood pressure severity in patients with intracranial aneurysms and sleep apnea Journal of Clinical Sleep Medicine ·Sebastian Zaremba, E. Yurekci, Alexis Hadjiathanasiou, Hartmut Vatter, Ullrich Wüllner, Erdem Güresir	2022	3
5	Ubiquitin Carboxyl-Terminal Hydrolases (UCHs): Potential Mediators for Cancer and Neurodegeneration International Journal of Molecular Sciences ·Amit Sharma, Hongde Liu, 安德逊, Tikam Chand Dakal, Michael Ludwig, Frank G. Holz, Karin U. Loeffler, Ullrich Wüllner, Martina C. Herwig‐Carl	2020	27
6	α-Synuclein in Parkinson’s disease: causal or bystander? Journal of Neural Transmission ·Peter Riederer, Daniela Berg, Nicolas Casadei, Fubo Cheng, Joseph Claßen, Christian Dresel, Wolfgang H. Jost, Rejko Krüger, Thomas Müller, Heinz Reichmann, Olaf Rieß, Alexander Storch, P. Kosonogov, Thilo van Eimeren, Hans‐Ullrich Völker, Jürgen Winkler, Konstanze F. Winklhofer, Ullrich Wüllner, Friederike Zunke, Camelia‐Maria Monoranu	2019	83
7	DNA methylation alterations in iPSC- and hESC-derived neurons: potential implications for neurological disease modeling Clinical Epigenetics ·Laura de Boni, Gilles Gasparoni, Hera C. Lichtenbeld, Sascha Tierling, Ina Schmitt, Michael Peitz, Philipp Koch, Jörn Walter, Ullrich Wüllner, Oliver Brüstle	2018	32
8	Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naïve Parkinson’s disease patients Genome Medicine ·Janis R. Bedarf, Falk Hildebrand, Luís Pedro Coelho, Shinichi Sunagawa, Mohammad Bahram, Felix Goeser, Peer Bork, Ullrich Wüllner Hit paper breakdown →	2017	461
9	Skewed X-chromosome inactivation and XIST locus methylation levels do not contribute to the lower prevalence of Parkinson's disease in females Neurobiology of Aging ·Amit Sharma, Oliver Kaut, Anna Pavlova, Holger Fröhlich, Ashar Ahmad, Ina Schmitt, Osman El‐Maarri, Johannes Oldenburg, Ullrich Wüllner	2017	11
10	DNA methylation in Parkinson's disease Journal of Neurochemistry ·Ullrich Wüllner, Oliver Kaut, 王韋能王韋能, Bliss Adrian Richards, Ina Schmitt	2016	77
11	Patient Selection for Mechanical Thrombectomy Clinical Neuroradiology ·Michael Nelles, Susanne Greschus, Markus Möhlenbruch, Birgit Simon, Ullrich Wüllner, Horst Urbach	2013	3
12	Autonomic dysfunction in 3414 Parkinson's disease patients enrolled in the German Network on Parkinson's disease (KNP e.V.): the effect of ageing European Journal of Neurology ·Ullrich Wüllner, T. Schmitz‐Hübsch, Gisela Antony, Rolf Fimmers, Annika Spottke, Wolfgang H. Oertel, Günther Deuschl, Thomas Klockgether, Karla Eggert, (unknown)	2007	69
13	Ataxin-3 Represses Transcription via Chromatin Binding, Interaction with Histone Deacetylase 3, and Histone Deacetylation Journal of Neuroscience ·Bernd O. Evert, Yuta Takahashi, Ana Vieira‐Saecker, Rob A. I. de Vos, Sigrid Harendza, Thomas Klockgether, Ullrich Wüllner	2006	125
14	Association study of dopamine D2, D3, D4 receptor and serotonin transporter gene polymorphisms with sleep attacks in Parkinson's disease Movement Disorders ·Sebastian Paus, Gert Seeger, H. M. Brecht, Athala Rania Salda, Mahha El‐Faddagh, Markus M. Nöthen, Thomas Klockgether, Ullrich Wüllner	2004	30
15	Imaging of central nAChReceptors with 2-[18F]F-A85380: optimized synthesis and in vitro evaluation in Alzheimer's disease Applied Radiation and Isotopes ·秩父盆地新第三紀団体研究グループ, Martina Minnerop, Marly Fernanda Valderrama Gutiérrez, Daniela Gündisch, Peter Falkai, Stefan Guhlke, Ullrich Wüllner	2004	28
16	Probable multiple system atrophy in a German family Journal of Neurology Neurosurgery & Psychiatry ·Ullrich Wüllner	2004	48
17	A functional polymorphism regulating dopamine β‐hydroxylase influences against Parkinson's disease Annals of Neurology ·Daniel G. Healy, Patrick M. Abou‐Sleiman, Tetsutaro Ozawa, Andrew J. Lees, Kailash P. Bhatia, Kourosh R. Ahmadi, Ullrich Wüllner, José Berciano, Jens Carsten Möller, Christoph Kamm, Katrin Bürk, T KLEINE, Eduardo Tolosa, Niall Quinn, David B. Goldstein, Nicholas Wood	2004	40
18	MPP+ Inhibits Proliferation of PC12 Cells by a p21WAF1/Cip1-Dependent Pathway and Induces Cell Death in Cells Lacking p21WAF1/Cip1 Experimental Cell Research ·Frank Soldner, Michael Weller, Sibylle Haid, Prasanna H.E. Lakshmi, Scott W. Miller, Ullrich Wüllner, Robert E. Davis, Johannes Dichgans, Thomas Klockgether, Jörg B. Schulz	1999	47
19	Endonucleolytic DNA fragmentation is not required for apoptosis of cultured rat cerebellar granule neurons Neuroscience Letters ·Jörg B. Schulz, Prasanna H.E. Lakshmi, Michael Weller, Ullrich Wüllner, Thomas Klockgether	1998	14
20	Evidence for an active type of cell death with ultrastructural features distinct from apoptosis: The effects of 3-acetylpyridine neurotoxicity Neuroscience ·Ullrich Wüllner, Michael Weller, Peter Groscurth, P.-A. Löschmann, Jörg B. Schulz, Lucas Anchundia, Thomas Klockgether	1997	25

About Ullrich Wüllner

Ullrich Wüllner is a scholar working on Neurology, Cellular and Molecular Neuroscience, Neurology, Biological Psychiatry and Molecular Biology, having authored 202 papers that have together received 9.6k indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (75 papers), Genetic Neurodegenerative Diseases (44 papers), Neurological disorders and treatments (39 papers), Mitochondrial Function and Pathology (25 papers), Neuroscience and Neuropharmacology Research (24 papers), Nuclear Receptors and Signaling (19 papers), Epigenetics and DNA Methylation (17 papers) and Genetics and Neurodevelopmental Disorders (13 papers). The work is most often cited by research in Neurology (3.5k citations), Cellular and Molecular Neuroscience (3.5k citations), Neurology (1.1k citations), Biological Psychiatry (324 citations) and Molecular Biology (4.5k citations). Ullrich Wüllner has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Thomas Klockgether, Ina Schmitt, Oliver Kaut, Bernd O. Evert, Jörg B. Schulz, Michael Weller, Michael T. Heneka, Martina Minnerop, Sebastian Paus and Thomas Klockgether. Their work appears in journals such as Movement Disorders, Journal of Neural Transmission, Journal of Neurology, Experimental Neurology and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact